tiprankstipranks
Corbus Pharmaceuticals (CRBP)
NASDAQ:CRBP
US Market
CRBP
Corbus Pharmaceuticals
RESEARCH TOOLSreports
Want to see CRBP full AI Analyst Report?

Corbus Pharmaceuticals (CRBP) Income Statement

2,552 Followers

Corbus Pharmaceuticals Income Statement

Last quarter (Q4 2025), Corbus Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Corbus Pharmaceuticals's net income was $-20.55M. See Corbus Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 881.71K
Gross Profit
$ -233.00K$ -600.00K$ 0.00$ -1.49M$ -757.53K
Operating Expenses
$ 85.31M$ 48.12M$ 45.08M$ 33.35M$ 55.23M
Depreciation and Amortization
$ 233.00K$ 600.00K$ 641.00K$ 1.49M$ 1.64M
EBITDA
$ -85.08M$ -37.74M$ -40.10M$ -38.73M$ -54.35M
Operating Income
$ -85.31M$ -48.72M$ -45.08M$ -34.84M$ -55.99M
Other Income/Expenses
$ 6.77M$ 8.51M$ 474.00K$ -7.51M$ 10.35M
Pretax Income
$ -78.54M$ -40.21M$ -44.60M$ -42.35M$ -45.64M
Net Income
$ -78.54M$ -40.21M$ -44.60M$ -55.83M$ -45.55M
Per Share Metrics
Basic EPS
$ -5.90$ -3.68$ -10.31$ -10.15$ -11.11
Diluted EPS
$ -5.90$ -3.68$ -10.31$ -10.15$ -11.11
Weighted Average Shares Outstanding
 13.32M 10.91M 4.33M 4.17M 4.10M
Weighted Average Shares Outstanding (Diluted)
 13.32M 10.91M 4.33M 4.17M 4.10M
Currency in USD

Corbus Pharmaceuticals Earnings and Revenue History